News from aethlon medical, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:AEMD)

Feb 05, 2016, 09:32 ET
Aethlon Hemopurifier. (PRNewsFoto/Aethlon Medical, Inc.)

Aethlon Medical to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 10, 2016

Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at Source Capital Group's 2016...

Feb 04, 2016, 16:10 ET
Aethlon Hemopurifier. (PRNewsFoto/Aethlon Medical, Inc.)

Aethlon Medical Announces Fiscal 2016 Third Quarter Results

 Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...

Feb 03, 2016, 09:30 ET
Aethlon Hemopurifier. (PRNewsFoto/Aethlon Medical, Inc.)

Aethlon Medical Announces Dengue Virus Study Approval, Chikungunya Virus Capture Data and Completion of U.S. Principal Investigator Training

 Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that a human treatment study entitled: "A Clinical Safety Study of the Aethlon...

Feb 01, 2016, 09:30 ET
Aethlon Hemopurifier.

Aethlon Medical to Present at the 18th Annual BIO CEO & Investor Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the BIO CEO & Investor Conference...

Jan 29, 2016, 09:30 ET
Aethlon Hemopurifier. (PRNewsFoto/Aethlon Medical, Inc.)

Aethlon Medical To Host Third Quarter Fiscal 2016 Investor Call on February 4, 2016

 Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...

Jan 12, 2016, 09:00 ET
Aethlon Hemopurifier.

Aethlon Medical's Exosome Sciences To Participate In Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)

 Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. (Nasdaq:AEMD), announced today that it has agreed to...

Nov 16, 2015, 16:01 ET
Aethlon Hemopurifier.

Aethlon Medical Announces Fiscal 2016 Second Quarter Results

 Aethlon Medical, Inc. (Nasdaq:AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...

Nov 10, 2015, 09:30 ET
Aethlon Hemopurifier.

Aethlon Medical to Participate in the IN3 Medical Device 360 Summit

 Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...

Oct 26, 2015, 09:30 ET
Aethlon Hemopurifier.

Aethlon Medical To Host Second Quarter Fiscal 2016 Investor Call on November 16, 2015

Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today announced...

Sep 28, 2015, 14:45 ET
Aethlon Hemopurifier.

Aethlon Medical Extends Contract with the Defense Advanced Research Projects Agency

 Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that it has entered into an extension of its contract with the Defense Advanced Research...

Sep 02, 2015, 09:25 ET
Aethlon Hemopurifier.

Aethlon Medical to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

 Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the Rodman & Renshaw 17th...

Aug 13, 2015, 16:05 ET
Aethlon Hemopurifier.

Aethlon Medical Announces Fiscal 2016 First Quarter Results

 Aethlon Medical, Inc. (Nasdaq:AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...

Aug 06, 2015, 09:00 ET

Aethlon Medical (AEMD) CEO Note: Nasdaq listing, equity financing and therapeutic pipeline expansion

 Aethlon Medical, Inc. (Nasdaq: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. On July 24th, members of...

Aug 03, 2015, 09:00 ET
Aethlon Hemopurifier.

Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015

 Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...

Jul 21, 2015, 09:00 ET
Aethlon Hemopurifier.

Aethlon Medical to Ring the Nasdaq Stock Market Closing Bell on July 24th

Aethlon Medical, Inc. (NASDAQ:AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today announced...

Jul 13, 2015, 09:40 ET
Aethlon Hemopurifier.

Aethlon Medical Begins Trading on the Nasdaq Capital Market

 Aethlon Medical, Inc. (NASDAQ:AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...

Jul 08, 2015, 09:01 ET
Aethlon Hemopurifier.

Aethlon Medical Announces Nasdaq Capital Market Listing Approval

 Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today announced...

Jun 24, 2015, 08:07 ET
Aethlon Hemopurifier.

Aethlon Medical Announces $6 Million Equity Investment

 Aethlon Medical, Inc. (OTCQB:AEMD),  the pioneer in creating affinity biofiltration devices to treat life-threatening...

Jun 11, 2015, 09:05 ET
Aethlon Hemopurifier

Aethlon Medical Discloses Upcoming Presentations

Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, disclosed today...

Jun 09, 2015, 08:45 ET
Aethlon Hemopurifier

Aethlon Medical Announces Resignation of Inside Director to Comply with NASDAQ Corporate Governance Requirements

Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, announced today that...